Tunisia: Diabetes on the Rise
Diabetes is an important problem in Tunisia, with prevalence is expected to increase over the coming years. Jean-Francois Courtet, general manager of Novo Nordisk in Tunisia, points out rgar “diabetes…
The long-awaited conference marking the launch of the company cluster of Sidi Thabet (a city in the governorate of Ariana, 20 minutes from Tunis airport) took place on September 28th 2017 at the Tunis export centre (CEPEX) and revolved around…
Diabetes is an important problem in Tunisia, with prevalence is expected to increase over the coming years. Jean-Francois Courtet, general manager of Novo Nordisk in Tunisia, points out rgar “diabetes…
The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi operations; why India is calling for reform of the import process for pharma products…
Alya El Hedda, GM of Opalia-Recordati in Tunisia, describes the Opalia affiliate’s evolution since the Recordati takeover, her ambitions for the future, and how the company will leverage its production facilities – the largest in Tunisia – to become Recordati’s export hub for the rest of Africa and MENA. Could you begin by introducing Opalia-Recordati Tunisian affiliate? “Opalia-Recordati is a…
Saad Kanbris, who has been heading Novartis operations in Morocco, Tunisia & Libya since January 2018, discusses the importance of ‘the context’ and temporality while analyzing the improvement and the…
Jade Salhab, senior private sector development specialist at World Bank Tunisia, discusses the impact of the public-private dialogues initiated by his organization in Tunisia, and the additional measures needed to…
See our Cookie Privacy Policy Here
